Polo-Like Kinases Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3937-3948

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia?

By Tsykunova Galina   Reikvam Håkon   Ahmed Aymen Bushra   Nepstad Ina   Gjertsen Bjørn Tore   Bruserud Øystein  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 587-603

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Discovery of Polo-like Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 181-197

Bentham Science Publishers

Access to resources Recommend Favorite

Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1347-1350

Bentham Science Publishers

Access to resources Recommend Favorite

A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD)

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1194-1205

Bentham Science Publishers

Access to resources Recommend Favorite